Subscribe to RSS
DOI: 10.1055/s-0029-1242822
© Georg Thieme Verlag KG Stuttgart · New York
Acute Respiratory Distress due to Antipsychotic Drugs
Publication History
received 02.07.2009
revised 16.09.2009
accepted 06.10.2009
Publication Date:
16 December 2009 (online)
We report a 36-year-old male schizophrenic patient who was treated with risperidone for a long time. Because of an acute psychotic reaction, haloperidol, chlorpromazine and olanzapine were administered additionally. After administration of these drugs, he developed acute respiratory distress that caused his death. We discuss the cause of this respiratory distress and conclude that it might be due to acute laryngeal dystonia caused by these antipsychotic drugs. Antipsychotic drug-induced laryngeal dystonia is rarely reported but it is a life threatening side effect. All physicians dealing with antipsychotic drug therapy must be aware of acute laryngeal dystonia, and an antiparkinsonian agent should be administered immediately.
References
-
1 Baldessarini RJ, Tarazi FI. Pharmacotherapy of Psychosis and Mania. In: Brunton LL, Lazo JS, Parker KL, editors.
Goodman & Gilman's The Pharmacological Basis of Therapeutics . New York: McGraw-Hill 2006: 461-500 - 2 Barnes TR, McPhillips MA. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia. Int Clin Psychopharmacol.. 1998; 13 ((Suppl 3)) 49-57
- 3 Chakravarty AC. Neuroleptic-induced acute laryngeal dystonia causing stridor: A lesson to remember. Mov Disord. 2005; 20 1082-1083
- 4 Christodoulou C, Kalaitzi C. Antipsychotic drug-induced acute laryngeal dystonia: Two case reports and a mini review. J Psychopharmacol. 2005; 19 307-312
- 5 Farde L, Nyberg S, Oxenstierna G. et al . Positron emission tomography studies on D2 and 5HT2 receptor binding in risperidone-treated schizophrenic patients. J Clin Psychopharmacol. 1995; 15 19-23
- 6 Fines RE, Brady WJ, Martin ML. Acute laryngeal dystonia related to neuroleptic agents. Am J Emerg Med. 1999; 17 319-320
- 7 Ilchef R. Neuroleptic-induced laryngeal dystonia can mimic anaphylaxis. 1997; 31 877-879
- 8 Kapur S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry. 1999; 156 286-293
- 9 Koek RJ, Pi EH. Acute laryngeal dystonic reactions to antipsychotics. Psychosomatics. 1989; 30 359-364
- 10 Menuck M. Laryngeal-pharyngeal dystonia and haloperidol. Am J Psychiatry. 1981; 138 394-395
- 11 Modestin J, Krapf R, Böker W. A fatality during haloperidol treatment: mechanism of sudden death. Am J Psychiatry. 1981; 138 1616-1617
- 12 Murray V. Laryngeal dystonia. Br J Psychiatry. 1996; 167 698-699
- 13 Newton-John H. Acute upper airway obstruction due to supraglottic dystonia induced by a neuroleptic. BMJ. 1988; 297 ((6654)) 964-965
- 14 Nordstrom AL, Nyberg S, Olsson H. et al . Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients. Arch Gen Psychiatry. 1998; 55 283-284
- 15 Peek DF. A patient with haloperidol induced laryngeal dystonia. Acta Anaesthesiol Belg. 2008; 59 103-105
- 16 Raja M, Azzoni A. Novel antipsychotics and acute dystonic reactions. Int J Neuropsychopharmacol. 2001; 4 393-397
- 17 Rupniak NM, Jenner P, Marsden CD. Acute dystonia induced by neuroleptic drugs. Psychopharmacology. 1986; 88 403-419
- 18 Russel SA, Hennes HM, Herson KJ. et al . Upper airway compromise in acute cholorpromazine ingestion. Am J Emerg Med. 1996; 14 467-468
- 19 Sramek JJ, Simpson GM, Morrison RL. et al . Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study. J Clin Psychiatry. 1986; 47 305-319
- 20 Stevens CB. Acute laryngeal dystonic reactions to antipsychotics. 1990; 31 236-237
- 21 Collaborative Working Group on Clinical Trial Evaluations . Assessment of EPS and tardive dyskinesia in clinical trials. J Clin Psychiatry. 1998; 59 ((Suppl 12)) 23-27
1 This paper was presented at the Congress of the International Academy of Legal Medicine, Porto, P.E37, 29 May 2009.
Correspondence
H. B. UlusoyMD
Department of Pharmacology
Erciyes University Faculty of Medicine
38039 Kayseri
Turkey
Phone: +90/533/343 0702
Fax: +90/352/437 5285
Email: ulusoyhb@yahoo.com
Email: ulusoy@erciyes.edu.tr